Eli Lilly and Company (NYSE:LLY) is a global pharmaceutical company headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company researches, develops, manufactures and markets medicines for a range of conditions, including diabetes, obesity, cancer, immunological disorders, neurological diseases and pain.
Its products include Mounjaro and Zepbound, which contain tirzepatide and are used for type 2 diabetes and chronic weight management, respectively. Other key medicines include Trulicity for diabetes, Verzenio for certain breast cancers, Taltz for inflammatory and autoimmune conditions, Humalog insulin, and Kisunla for early symptomatic Alzheimer's disease. Lilly also markets Jardiance through an alliance with Boehringer Ingelheim.
Lilly serves patients and healthcare providers in the United States and international markets across North America, Europe, Asia and other regions. The company operates research, manufacturing and commercial facilities worldwide and distributes its medicines through healthcare systems, pharmacies and other channels.
David A. Ricks serves as Eli Lilly's chairman and chief executive officer. Under his leadership, the company has emphasized pharmaceutical research and expanded its focus on metabolic, oncology, immunology and neuroscience treatments.
